Pulmonx
(NASDAQ) LUNG
Pulmonx Financials at a Glance
Market Cap
$54.06M
Revenue (TTM)
$88.55M
Net Income (TTM)
-$53.21M
EPS (TTM)
-$1.29
P/E Ratio
-0.99
Dividend
$0.00
Beta (Volatility)
1.34 (Average)
Dividend
$0.00
Beta (Volatility)
1.34 (Average)
Price
$1.31
Volume
1,922
Open
$1.30
Price
$1.31
Volume
1,922
Open
$1.30
Previous Close
$1.28
Daily Range
$1.30 - $1.32
52-Week Range
$1.13 - $3.88
Estimated Earnings Date
Jul 29, 2026
Dividend
$0.00
Beta (Volatility)
1.34 (Average)
Price
$1.31
Volume
1,922
Open
$1.30
Previous Close
$1.28
Daily Range
$1.30 - $1.32
52-Week Range
$1.13 - $3.88
Estimated Earnings Date
Jul 29, 2026
LUNG News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Pulmonx
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
296
CEO
Glendon E. French, MBA
Website
www.pulmonx.comHeadquarters
Redwood City, CA 94063, US
LUNG Financials
Key Financial Metrics (TTM)
Gross Margin
75.49%
Operating Margin
-58.79%
Net Income Margin
-60.09%
Return on Equity
-92.94%
Return on Capital
-48.57%
Return on Assets
-44.35%
Earnings Yield
-1.01%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$54.06M
Shares Outstanding
42.24M
Volume
1.92K
Avg. Volume
425.30K
Financials (TTM)
Gross Profit
$66.84M
Operating Income
-$52.06M
EBITDA
-$48.22M
Operating Cash Flow
-$29.30M
Capital Expenditure
-$160.00K
Free Cash Flow
-$29.46M
Cash & ST Invst.
$61.57M
Total Debt
$56.29M
Pulmonx Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$20.59M
-8.7%
Gross Profit
$16.04M
-1.8%
Gross Margin
77.94%
N/A
Market Cap
$54.06M
N/A
Market Cap/Employee
$185.79K
N/A
Employees
291
N/A
Net Income
-$13.65M
+5.5%
EBITDA
-$12.31M
+15.5%
Quarterly Fundamentals
Total Cash
$61.57M
-30.6%
Total Debt
$56.29M
-1.2%
Accounts Receivable
$11.27M
-22.8%
Inventory
$16.31M
-3.0%
Long Term Debt
$54.95M
+14.4%
Short Term Debt
$1.34M
-84.9%
Return on Assets
-44.35%
N/A
Return on Invested Capital
-51.51%
N/A
Free Cash Flow
-$10.11M
+25.3%
Operating Cash Flow
-$10.10M
+23.6%